Clinical Trials Directory

Trials / Completed

CompletedNCT03256162

Ketamine as an Adjunctive Therapy for Major Depression

Ketamine as an Adjunctive Therapy for Major Depression - a Randomised Controlled Pilot Trial: The KARMA-Dep Trial

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
25 (actual)
Sponsor
St Patrick's Hospital, Ireland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Randomised, controlled, parallel-group, pilot clinical trial of ketamine vs. midazolam as an adjunctive therapy for depression. The main purpose of the pilot study is to assess trial processes to help inform a future definitive trial.

Detailed description

Pragmatic, randomised, controlled, parallel-group, pilot trial. Trial participants will be patients admitted to St Patrick's University Hospital for treatment of a depressive episode. The investigators aim to recruit up to 20 participants who will be eligible for this study and randomly allocate 10 patients to each group. The participants will undergo usual inpatient care as prescribed by their treating team for the index acute depressive episode. Both participants and assessors will be blind to treatment allocation. Consented participants will be randomly allocated in a 1:1 ratio to a four week course of either once-weekly ketamine or midazolam infusions. Block randomisation will be independently performed. Physical, psychotomimetic and cognitive outcomes will be monitored before, during and after infusions. Blood samples will be taken at four time-points in the first infusion session and before the final infusion for neuroplasticity biomarker studies. Both groups will continue treatment as usual. Participates will also be followed up over a three month period.

Conditions

Interventions

TypeNameDescription
DRUGKetamineA sub-anaesthetic dose of ketamine will be administered in four infusions, each one week apart.
DRUGMidazolamA sub-anaesthetic dose of midazolam will be administered in four infusions, each one week apart.

Timeline

Start date
2017-09-07
Primary completion
2018-09-21
Completion
2018-09-21
First posted
2017-08-21
Last updated
2020-01-18
Results posted
2020-01-18

Locations

1 site across 1 country: Ireland

Source: ClinicalTrials.gov record NCT03256162. Inclusion in this directory is not an endorsement.